Metformin Treatment Modulates Long Non-Coding RNA Isoforms Expression in Human Cells.
Ontology highlight
ABSTRACT: Long noncoding RNAs (lncRNAs) undergo splicing and have multiple transcribed isoforms. Nevertheless, for lncRNAs, as well as for mRNA, measurements of expression are routinely performed only at the gene level. Metformin is the first-line oral therapy for type 2 diabetes mellitus and other metabolic diseases. However, its mechanism of action remains not thoroughly explained. Transcriptomic analyses using metformin in different cell types reveal that only protein-coding genes are considered. We aimed to characterize lncRNA isoforms that were differentially affected by metformin treatment on multiple human cell types (three cancer, two non-cancer) and to provide insights into the lncRNA regulation by this drug. We selected six series to perform a differential expression (DE) isoform analysis.
SUBMITTER: Conceicao IMCAD
PROVIDER: S-EPMC9607547 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA